

Annual Report 2016-17
•
129
[vii.
American Depository Receipts / Global Depository Receipts / Warrants
As on March 31, 2017, the Company has no American Depository Receipts / Global Depository Receipts / :arrants or any
such convertible instruments outstanding and there is no likely impact on the Company’s Equity Shares in the onancial
year 2016-17.
[viii.
Plant locations
The Company is in software business and does not require manufacturing plants. However, it has software development
centers / ofoces in India and abroad. The addresses of global development centers / ofoces of the Company are given
elsewhere in the Annual Report.
[i[.
Calendar for declaring the onancial statements for the quarters in the onancial year 2017-18 (tentative and
subject to change)
Quarter Ending
Proposed date of meeting of the Board
June 30, 2017
July 20 and July 21, 2017
September 30, 2017
October 15 and October 16, 2017
December 31, 2017
January 19, 2018 and January 20, 2018
March 31, 2018
April 20, 2018 and April 21, 2018
11. ESOP Schemes of the Company
The status of various ESOP schemes as on March 31, 2017 is shown in the following table:
Scheme
i
ii
iii
iv
v
vi
vii
viii
ix
x
xi
xii
Total
Granted
a 4,560,500 753,200 2,533,300 6,958,250 1,890,525 1,216,250 1,784,975 42,000 1,374,462 3,062,272 492,000 67,300 24,735,034
Vested
b 3,214,785 477,085 1,694,802 4,704,472 1,333,792 785,750 796,455 28,000 914,710 2,236,617
-
-
16,186,468
E[ercised
c 3,208,202 472,482 1,455,975 3,876,528 1,217,346 785,750 740,568 28,000 750,933 1,247,970
-
-
13,783,754
Vested but not
e[ercised (b - c)
d
6,583 4,603 238,827 827,944 116,446
-
55,887
-
163,777 988,647
-
-
2,402,714
/apsed
e 1,345,715 276,115 838,498 2,253,778 556,733 430,500 988,520 14,000 459,752 825,655 89,400
-
8,078,666
Not Vested
(a - c - d - e)
f
-
-
-
-
-
-
-
-
-
- 402,600 67,300 469,900
Total Outstanding
(d + f)
g
6,583 4,603 238,827 827,944 116,446
-
55,887
-
163,777 988,647 402,600 67,300 2,872,614
:eighted average
remaining contractual
life
Note(i)
4.46 Note(i)
5.84 Note(i)
-
5.57
-
6.03
1.51
1.25
0.25
:eighted Average
fair value of options
granted (in
`
)
4.69
19.55
26.12
37.38 24.64 25.06 36.97
48.21
54.74 202.70 583.66 700.50
*Note(i): No Contractual life is deoned in the scheme
12. CEO/CFO certiocation
As required by Regulation 17(8) of the /isting Regulations 2015, the CEO/CFO certiocation is provided elsewhere in this
Annual Report.
13. Corporate Governance Handbook
The Company has proactively and voluntarily prepared the Corporate Governance Handbook encompassing set of
guidelines and policies with respect to composition of the Board of Directors and Committees of the Board, meetings
of the Board of Directors and Committees of the Board, Managerial Remuneration, Code of Conduct, :histle Blower
Policy, Risk Management Policy, Internal Control Procedures etc., being adhered to by the Company. The Corporate
Governance Handbook is updated on an annual basis.